The content on this page is designed for Australia. Check courses designed for Canada (EN)

This course has expired. View available courses.

Medication Management

Optimising IV iron therapy: the importance of a patient-centred approach

Iron deficiency (ID) is the commonest nutritional deficiency in Australia and can adversely affect a patient’s quality of life. The principles of managing ID in primary care include making a confirmed diagnosis, identifying and addressing the underlying cause of ID, and correcting the deficiency with iron replacement therapy. The benefits of iron replacement therapy include improvements in fatigue, general health, mental health and quality of life. Because ID is significantly under-diagnosed in Australia, there is a major opportunity in general practice for individual and population health improvements through increased awareness and testing of ID, in addition to targeted iron supplementation.

This 1.5-hour RACGP accredited activity aims to empower GPs to improve ID diagnosis rates thereby increasing access to effective treatment with a focus on applying a person-centred approach to selecting intravenous (IV) iron replacement therapy and individualising dosing to ensure adequate iron repletion. It features two cases studies and expert video interviews from the faculty.


This educational activity was developed by MDBriefCase at the request, and with funding from Pfizer.

DURATION

2 hr

PROFESSION

Physician

# OF CREDITS

0

ACCREDITATION

RACGP CPD Program

EXPIRY DATE

2023-03-26

Iron deficiency (ID) is the commonest nutritional deficiency in Australia and can adversely affect a patient’s quality of life. The principles of managing ID in primary care include making a confirmed diagnosis, identifying and addressing the underlying cause of ID, and correcting the deficiency with iron replacement therapy. The benefits of iron replacement therapy include improvements in fatigue, general health, mental health and quality of life. Because ID is significantly under-diagnosed in Australia, there is a major opportunity in general practice for individual and population health improvements through increased awareness and testing of ID, in addition to targeted iron supplementation.

This 1.5-hour RACGP accredited activity aims to empower GPs to improve ID diagnosis rates thereby increasing access to effective treatment with a focus on applying a person-centred approach to selecting intravenous (IV) iron replacement therapy and individualising dosing to ensure adequate iron repletion. It features two cases studies and expert video interviews from the faculty.


This educational activity was developed by MDBriefCase at the request, and with funding from Pfizer.

Faculty

Professor Alhossain Khalafallah (Haematologist)

Dr Sandra Minck (GP)

Learning objectives

On completion of this program, GPs will be better able to:

  • Recognise the scale and extent of impact that iron deficiency (ID) and iron deficiency anaemia (IDA) has in the community, particular in certain subgroups
  • Identify patients at high risk of ID, including IDA, to improve diagnosis rates and access to effective treatment
  • Design an individualised approach to selecting IV iron replacement therapy based on optimising patient outcomes through defined targets
  • Determine and assess strategies to optimise tolerability and safety of IV iron replacement therapy

Accreditation

This activity has been approved for the following hours and types: 
Educational activities hours: 1
Reviewing performance hours: 1
Measuring outcomes hours: 0

Activity no. 480248

Cost of course:  
Free
# of credits: 0
Duration: 2 hr

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.